Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain.
Rullán
J V
JV
Instituto de Salud Carlos III, Ministerio de Sanidad y Consumo, Madrid, Spain.
Herrera
D
D
Cano
R
R
Moreno
V
V
Godoy
P
P
Peiró
E F
EF
Castell
J
J
Ibañez
C
C
Ortega
A
A
Agudo
L S
LS
Pozo
F
F
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology / Q000382:microbiology / Q000635:transmission*; D000328:Adult; D003428:Cross Infection; D004269:DNA, Bacterial / Q000032:analysis; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D005260:Female; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D012293:Rifampin / Q000627:therapeutic use; D013030:Spain / Q000453:epidemiology; D014376:Tuberculosis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000635:transmission*
D004269:DNA, Bacterial; D007538:Isoniazid; D012293:Rifampin